Cite
Randomized, Blinded, Placebo-Controlled Trial of De Simone Formulation Probiotic During HIV-Associated Suboptimal CD4 + T Cell Recovery.
MLA
Rousseau, Rodney K., et al. “Randomized, Blinded, Placebo-Controlled Trial of De Simone Formulation Probiotic During HIV-Associated Suboptimal CD4 + T Cell Recovery.” JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 89, no. 2, Feb. 2022, pp. 199–207. EBSCOhost, https://doi.org/10.1097/QAI.0000000000002840.
APA
Rousseau, R. K., Walmsley, S. L., Lee, T., Rosenes, R., Reinhard, R. J., Malazogu, F., Benko, E., Huibner, S., Kovacs, C. M., Singer, J., Kim, C. J., & Kaul, R. (2022). Randomized, Blinded, Placebo-Controlled Trial of De Simone Formulation Probiotic During HIV-Associated Suboptimal CD4 + T Cell Recovery. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 89(2), 199–207. https://doi.org/10.1097/QAI.0000000000002840
Chicago
Rousseau, Rodney K., Sharon L. Walmsley, Terry Lee, Ron Rosenes, Robert J. Reinhard, Fat Malazogu, Erika Benko, et al. 2022. “Randomized, Blinded, Placebo-Controlled Trial of De Simone Formulation Probiotic During HIV-Associated Suboptimal CD4 + T Cell Recovery.” JAIDS: Journal of Acquired Immune Deficiency Syndromes 89 (2): 199–207. doi:10.1097/QAI.0000000000002840.